Dyne Therapeutics, Inc. (DYN)
15.44
+0.24
(+1.58%)
USD |
NASDAQ |
Oct 05, 16:00
15.44
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics EPS Diluted (Quarterly) : -1.079 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.079 |
| March 31, 2026 | -0.7323 |
| December 31, 2025 | -0.7584 |
| September 30, 2025 | -0.7619 |
| June 30, 2025 | -0.9735 |
| March 31, 2025 | -1.050 |
| December 31, 2024 | -0.8751 |
| September 30, 2024 | -0.9628 |
| June 30, 2024 | -0.7038 |
| March 31, 2024 | -0.81 |
| December 31, 2023 | -1.085 |
| September 30, 2023 | -0.9853 |
| June 30, 2023 | -1.085 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.7845 |
| December 31, 2022 | -0.74 |
| September 30, 2022 | -0.799 |
| June 30, 2022 | -1.012 |
| March 31, 2022 | -0.6896 |
| December 31, 2021 | -1.005 |
| September 30, 2021 | -0.8297 |
| June 30, 2021 | -0.5849 |
| March 31, 2021 | -0.5047 |
| December 31, 2020 | -0.6358 |
| September 30, 2020 | -2.012 |
| December 31, 2019 | -0.119 |
| September 30, 2019 | -0.1292 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.386 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -178.56M |
| Total Expenses (Quarterly) | 178.56M |
| Enterprise Value | 1.893B |
| Earnings Yield | -21.58% |
| Normalized Earnings Yield | -21.58 |